Resources for Patients and their Families
Request Free Guide

Mesothelioma Doctors

Michael J. Liptay, M.D.

Dr. Liptay
Chicago, IL

Dr. Michael J. Liptay

Head of the Division of Thoracic Surgery

Rush University Cancer Center

Rush Professional Office Building
1725 W. Harrison Street, Suite 774
Chicago, IL 60612
(312) 738-3732

Need Help Contacting This Doctor?

Northwestern University

Northwestern University’s Feinberg School of Medicine - 1988

Barnes-Jewish Hospital

Brigham and Women’s Hospital/Harvard Medical

As head of Rush University Medical Center’s Division of Thoracic Surgery, Dr. Michael J. Liptay is at the helm of the largest thoracic surgery practice in the city of Chicago. His division also boasts the most experience with minimally invasive surgery techniques in the entire Midwest. Dr. Liptay is the author of more than 100 manuscripts, book chapters and scholarly reports and has delivered lectures to experts around the world about his cancer research.

Educational Background

Dr. Liptay received his bachelor’s degree from Northwestern University, a private research university in the suburbs of Chicago, and graduated from the honors program at Northwestern University’s Feinberg School of Medicine. After receiving his medical degree, he completed a residency in general surgery at the Barnes-Jewish Hospital/Washington University in St. Louis. He also completed a fellowship in thoracic surgery at Brigham and Women’s Hospital/Harvard Medical School in Boston, where he researched alongside fellow mesothelioma expert Dr. David Sugarbaker, that school’s chief of thoracic surgery. Before joining Rush University Medical Center, Dr. Liptay served as chief of the Division of Thoracic Surgery at Evanston Northwestern Healthcare.

Clinical and Laboratory Research

The main focus of Dr. Liptay’s research is the early detection, staging and prognosis of lung cancer; he is considered one of Chicago’s leading lung cancer experts and an innovator in the field of thoracic surgery. Currently, his team is working on a serum blood test for the detection of lung cancer. In addition to his work leading the Division of Thoracic Surgery at Rush University Medical Center, Dr. Liptay holds several other leadership positions at the university. He serves as vice-chairperson in the university’s Department of Cardiovascular-Thoracic Surgery, medical director of the Coleman Foundation Chest Tumor Clinic, and is an associate professor at the Rush Medical College.

Additional Work

Dr. Liptay is active in numerous organizations in the medical profession. He serves as the American Medical Association House of Delegates representative for the American Association of Thoracic Surgery, is the editor of Thoracic Surgical News, serves on the editorial board of the Journal of Thoracic and Cardiovascular Surgery, and is a member of the Society of Thoracic Surgeons Database Task Force.

Relevant Publications

Extrapleural pneumonectmony in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg 1996; 224(3):288-194.
Sugarbaker DJ, Garcia JP, Richards WG, Harpole DH Jr., Healty-Baldini E. DeCamp MM Jr, Mentzer SJ, Liptay MJ, Strauss GM, Swanson SJ.

Biomarkers of the Insulin-Like Growth Factor Pathway Predict Progression and Outcome in Lung Cancer.
Shersher DD, Vercillo MS, Fhied C, Basu S, Rouhi O, Mahon B, Coon JS, Warren WH, Faber LP, Hong E, Bonomi P, Liptay MJ, Borgia JA. Ann Thorac Surg. 2011 Sep 24

Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients.
Gielda BT, Marsh JC, Zusag TW, Faber LP, Liptay M, Basu S, Warren WH, Fidler MJ, Batus M, Abrams RA, Bonomi P. J Thorac Oncol. 2011 Jun 6(6):1079-86.

Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.
Kim AW, Liptay MJ, Bonomi P, Warren WH, Basu S, Farlow EC, Faber LP. Ann Thorac Surg. 2011 Jul 92(1):233-41; discussion 241-3

Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer.
Kim AW, Batus M, Myint R, Fidler MJ, Basu S, Bonomi P, Faber LP, Wightman SC, Warren WH, McIntire M, Arvanitis LD, Gattuso P, Xu X, Liptay MJ. Lung Cancer 2011 Feb 71(2):186-90

Author: Linda Molinari

Editor in Chief, Mesothelioma Cancer Alliance

Linda Molinari

Reviewer: Annette Charlevois

Patient Support Coordinator

Annette Charlevois


Rush University Medical Center – Michael J. Liptay, M.D.

Rush University Medical Center – Thoracic Surgery Team

Rush University Medical Center – Michael J. Liptay, M.D.

Mesothelioma Treatment Guide

Free Mesothelioma Treatment Guide

Please fill in the form below to request our FREE Mesothelioma Treatment Guide. It will be sent to you within 24 hours.

Have you or someone you know been diagnosed with mesothelioma?

Get Access To:

Legal Rights Information Guide Free Guide Request Free Guide Free Mesothelioma Guide Free 2019 Mesothelioma Guide